Hoffmann-LA Roche is a global leader in personalized healthcare, made unique by its ability to combine pharmaceuticals and diagnostics. The company values treatment choices based on a patient's genetic makeup, believing treatments should be tailored to the biology of patient’s diseases — not just his or her symptoms.
In Canada, Roche stands out as a leader in clinical trial recruitment, accounting for 6% of Roche's global clinical research spending. It focuses on developing medicines and diagnostic tests that will help patients live longer, better lives. Hoffmann-LA Roche strives to address unmet medical needs through early detection and prevention of diseases to diagnosis, treatment, and treatment monitoring.
The Manitoba government is providing $500,000 to help Manitoba companies pursue new opportunities to export and diversify markets for their products, Economic Development, Investment and Trade Minister Jeff Wharton announced today.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.